New GLP-1 drugs: more power, fewer side effects

New GLP-1 drugs: more power, fewer side effects

September 5, 2026 · 8 min

About this episode

Luke O’Neill discusses the latest advancements in GLP-1 drugs following a biomedical conference in Oxford.

Luke O’Neill joins Pat Kenny fresh from a major biomedical conference in Oxford, where he met the scientists behind Ozempic and Mounjaro and heard the latest eye-opening data.

People in this episode

Host: Pat Kenny

Guest: Luke O’Neill

Topics covered

Keywords

Mentioned in this episode

Organizations: Ozempic, Mounjaro

Places: Oxford

More episodes of The Pat Kenny Show

Explore listener stats, chart rankings, contacts and more on the The Pat Kenny Show podcast page.